Application of the statistical method to convert published PASI 50/75/90/100 into absolute PASI response rate in patients with moderate-to-severe plaque psoriasis treated with tildrakizumab based on data from the two pivotal phase 3 studies reSURFACE 1 and reSURFACE 2 (P1296)

Autor: Dykukha, Igor, Schoenenberger A, Kasujee I, Mrowietz U, Vonthein R
Jazyk: angličtina
Rok vydání: 2020
DOI: 10.13140/rg.2.2.16174.54080
Databáze: OpenAIRE